
Mostra i principali dati dell'item
| dc.contributor.author | Rodríguez González, Cristina | |
| dc.contributor.author | Agulla Freire, Jesús | |
| dc.contributor.author | Delgado Esteban, María | |
| dc.date.accessioned | 2024-02-06T13:38:53Z | |
| dc.date.available | 2024-02-06T13:38:53Z | |
| dc.date.issued | 2021-01 | |
| dc.identifier.citation | Rodriguez, C., Agulla, J., & Delgado-Esteban, M. (2021). Refocusing the brain: new approaches in neuroprotection against ischemic injury. Neurochemical Research, 46(1), 51-63. https://doi.org/10.1007/s11064-020-03016-z | es_ES |
| dc.identifier.issn | 0364-3190 | |
| dc.identifier.uri | http://hdl.handle.net/10366/155415 | |
| dc.description.abstract | [EN]A new era for neuroprotective strategies is emerging in ischemia/reperfusion. This has forced to review the studies existing to date based in neuroprotection against oxidative stress, which have undoubtedly contributed to clarify the brain endogenous mechanisms, as well as to identify possible therapeutic targets or biomarkers in stroke and other neurological diseases. The efficacy of exogenous administration of neuroprotective compounds has been shown in different studies so far. However, something must be missing to get these treatments successfully applied in the clinical environment. Here, the mechanisms involved in neuronal protection against physiological level of ROS and the main neuroprotective signaling pathways induced by excitotoxic and ischemic stimuli are reviewed. Also, the endogenous ischemic tolerance in terms of brain self-protection mechanisms against subsequent cerebral ischemia is revisited to highlight how the preconditioning has emerged as a powerful tool to understand these phenomena. A better understanding of endogenous defense against exacerbated ROS and metabolism in nervous cells will therefore aid to design pharmacological antioxidants targeted specifically against oxidative damage induced by ischemic injury, but also might be very valuable for translational medicine. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Springer | es_ES |
| dc.subject | Ischemic preconditioning | es_ES |
| dc.subject | Neurons | es_ES |
| dc.subject.mesh | Oxidative Stress | * |
| dc.subject.mesh | Neurons | * |
| dc.subject.mesh | Brain Ischemia | * |
| dc.subject.mesh | Ischemic Preconditioning | * |
| dc.subject.mesh | Reactive Oxygen Species | * |
| dc.subject.mesh | Animals | * |
| dc.subject.mesh | Astrocytes | * |
| dc.subject.mesh | Humans | * |
| dc.subject.mesh | Gene Expression | * |
| dc.subject.mesh | Neuroprotective Agents | * |
| dc.title | Refocusing the brain: New approaches in neuroprotection against ischemic injury | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publishversion | https://doi.org/10.1007/s11064-020-03016-z | es_ES |
| dc.identifier.doi | 10.1007/s11064-020-03016-z | |
| dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | es_ES |
| dc.identifier.pmid | 32189131 | |
| dc.identifier.essn | 1573-6903 | |
| dc.journal.title | Neurochemical Research | es_ES |
| dc.volume.number | 46 | es_ES |
| dc.issue.number | 1 | es_ES |
| dc.page.initial | 51 | es_ES |
| dc.page.final | 63 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |
| dc.subject.decs | fármacos neuroprotectores | * |
| dc.subject.decs | astrocitos | * |
| dc.subject.decs | animales | * |
| dc.subject.decs | humanos | * |
| dc.subject.decs | estrés oxidativo | * |
| dc.subject.decs | isquemia cerebral | * |
| dc.subject.decs | neuronas | * |
| dc.subject.decs | expresión génica | * |
| dc.subject.decs | especies reactivas de oxígeno | * |
| dc.subject.decs | preacondicionamiento isquémico | * |







